CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study

CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study

Abstract Adult patients with relapsed or refractory T‐cell acute lymphoblastic leukemia (R/R‐T‐ALL) have extremely poor prognosis, representing an urgent unmet medical need. Finding an optimal salvage regimen to bridge transplantation is a priority. The CAG (cytarabine, aclarubicin, and G‐CSF) regim...

Full description

Bibliographic Details
Main Authors: Jie‐Jing Qian, Xiaoxia Hu, Ying Wang, Yi Zhang, Juan Du, Min Yang, Hongyan Tong, Wen‐Bin Qian, Juying Wei, Wenjun Yu, Yin‐Jun Lou, Liping Mao, Hai Tao Meng, Liang‐Shun You, Libing Wang, Xia Li, Xin Huang, Li‐Hong Cao, Jian‐Zhi Zhao, Xiao Yan Yan, Yu‐Bao Chen, Yu Chen, Su‐Jiang Zhang, Jie Jin, Jiong Hu, Hong‐Hu Zhu
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Cancer Medicine
Subjects:
refractory or relapse
stem cell transplantation
T‐cell acute lymphoblastic leukemia
Online Access:https://doi.org/10.1002/cam4.3079

Internet

https://doi.org/10.1002/cam4.3079

Similar Items